Oh, the ever-so-capricious Interleukin-22 (IL-22), a true Jekyll and Hyde of the cytokine world, as reported by the venerable pages of Kidney International and its scholarly kin. This little protein is quite the drama queen in the renal theater, playing both the villain and the hero in the gripping saga of acute kidney injury. Plot twist: during the nail-biting necroinflammation phase, IL-22 is caught red-handed pushing tubular cells off the cliff of mortality. But wait, there’s a redemption arc! In the tear-jerking recovery phase, our protagonist switches gears, promoting a veritable renaissance of epithelial cells and barrier function. Bravo, IL-22, for your context-dependent performance; you’ve truly mastered the art of keeping the scientific audience on the edge of their seats.